Next-Generation Blood Culture Analysis System
Legal Citation
Summary of the Inventive Concept
A revolutionary system integrating blood sequestration devices with real-time analysis capabilities, enabling rapid diagnosis and targeted treatment of microbial infections.
Background and Problem Solved
The original patent's blood sequestration device, while effective, has limitations in terms of speed and accuracy of diagnosis. The present inventive concept addresses these limitations by incorporating advanced microfluidic and machine learning technologies to provide real-time blood culture analysis, enabling caregivers to respond promptly to microbial infections.
Detailed Description of the Inventive Concept
The next-generation blood culture analysis system comprises a microfluidic chip integrated with a blood sequestration device, which collects a blood sample and analyzes it in real-time using machine learning-based algorithms to identify microbial infections. The system can be configured as a wearable device, transmitting samples to a remote analysis center for diagnosis. Alternatively, the system can be implemented as a network of interconnected blood sequestration devices, providing a comprehensive view of a patient's blood health across multiple sampling sites. The system's advanced analytics enable personalized treatment recommendations based on a patient's genomic profile.
Novelty and Inventive Step
The integration of microfluidic and machine learning technologies with blood sequestration devices represents a significant departure from the original patent, providing a paradigm shift in blood culture analysis. The inventive concept's real-time analysis capabilities, wearable and networked configurations, and personalized treatment recommendations constitute novel and non-obvious advancements.
Alternative Embodiments and Variations
Alternative embodiments may include handheld or portable devices, implantable sensors, or cloud-based analysis platforms. Variations may involve different microfluidic chip designs, machine learning algorithms, or genomic profiling techniques.
Potential Commercial Applications and Market
The next-generation blood culture analysis system has vast commercial potential in the healthcare industry, particularly in hospitals, clinics, and remote patient monitoring settings. The system's ability to provide rapid and accurate diagnoses can significantly reduce healthcare costs and improve patient outcomes, making it an attractive solution for healthcare providers and patients alike.
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Medical device engineering, specifically blood collection and diagnostic systems, with expertise in microfluidics, needle design, and medical instrumentation
Person of Ordinary Skill (PHOSITA) Profile
A biomedical engineer or medical device designer with advanced degree, working knowledge of blood collection technologies, microfluidic systems, and diagnostic instrumentation, familiar with emerging medical sensing and analysis techniques
Obviousness Rationale
A PHOSITA would recognize that integrating machine learning and microfluidic analysis with existing blood sequestration devices represents a predictable technological evolution. The source patent's fundamental blood collection mechanism provides a natural foundation for advanced diagnostic capabilities. The proposed variations leverage known technological trends in personalized medicine and real-time medical diagnostics.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,320 |
|---|---|
| Title | Blood sequestration device and method |
| Assignee(s) | Smiths Medical ASD, Inc. |